Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?

BACKGROUND: Women with polycystic ovary syndrome (PCOS) are at increased risk for cardiovascular (CV) and metabolic disorders. There is a close relationship between elevated androgen plasma levels and the ultrasound findings of stromal hypertrophy. In randomized trials, the administration of metform...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gharakhani, Mohsen, Neghab, Nosrat, Farimani, Marzie
Formato: Artigo
Idioma:Inglês
Publicado em: Royan Institute 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4059955/
https://ncbi.nlm.nih.gov/pubmed/24963365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados